Extracellular vesicles as personalized medicine

DJ Beetler, DN Di Florio, KA Bruno, T Ikezu… - Molecular aspects of …, 2023 - Elsevier
Extracellular vesicles (EVs) are released from all cells in the body, forming an important
intercellular communication network that contributes to health and disease. The contents of …

Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma

X Guo, R Sui, H Piao - Journal of Nanobiotechnology, 2022 - Springer
Small extracellular vesicles (SEVs) are extracellular vesicles containing DNA, RNA, and
proteins and are involved in intercellular communication and function, playing an essential …

Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast …

DN Kumar, A Chaudhuri, D Dehari, A Shekher… - Life, 2022 - mdpi.com
Paclitaxel (PAC) has been approved by FDA for clinical use (Taxol®), yet dose-dependent
severe toxicity due to the adjuvant Cremophor EL® in combination with ethanol is a major …

Membrane protein modification modulates big and small extracellular vesicle biodistribution and tumorigenic potential in breast cancers in vivo

BJA Magoling, AYT Wu, YJ Chen… - Advanced …, 2023 - Wiley Online Library
Extracellular vesicles (EVs) are released by cells to mediate intercellular communication
under pathological and physiological conditions. While small EVs (sEVs;< 100–200 nm …

[HTML][HTML] Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer

J Deng, T Pan, C Lv, L Cao, L Li, X Zhou, G Li, H Li… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Recently years have seen the increasing evidence identifying that OXPHOS is
involved in different processes of tumor progression and metastasis and has been proposed …

[HTML][HTML] Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis

D Brena, MB Huang, V Bond - Translational oncology, 2022 - Elsevier
Breast cancer metastatic progression to critical secondary sites is the second leading cause
of cancer-related mortality in women. While existing therapies are highly effective in …

Exosomes in bone remodeling and breast cancer bone metastasis

L Sadu, RH Krishnan, RL Akshaya, UR Das… - Progress in Biophysics …, 2022 - Elsevier
Exosomes are endosome-derived microvesicles that carry cell-specific biological cargo,
such as proteins, lipids, and noncoding RNAs (ncRNAs). They play a key role in bone …

[HTML][HTML] Exosomes: Insights and therapeutic applications in cancer

AR Panigrahi, L Srinivas, J Panda - Translational Oncology, 2022 - Elsevier
Cancer refers to the division of abnormal cells at an uncontrollable rate that possesses the
ability to infiltrate and destroy normal tissues. It frequently spreads to normal tissues …

Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma

X Gao, B Gao, S Li - Frontiers in Immunology, 2022 - frontiersin.org
Osteosarcoma (OS) is a primary bone cancer that is highly prevalent among adolescents
and adults below the age of 20 years. The prognostic outcome of metastatic OS or relapse is …

[HTML][HTML] Liquid Biopsies: Emerging role and clinical applications in solid tumours

S Sisodiya, V Kasherwal, A Khan, B Roy, A Goel… - Translational …, 2023 - Elsevier
Late detection and lack of precision diagnostics are the major challenges in cancer
prevention and management. Biomarker discovery in specific cancers, especially at the pre …